Remimazolam alleviates hepatic ischemia-reperfusion injury by activating FOXO1/3 signaling
Abstract Background Hepatic ischemia reperfusion injury (HIRI) frequently gives rise to aggravated liver damage. Currently, there exists a diverse range of anesthetic drugs that possess protective capabilities against ischemia-reperfusion injury (IRI). Nevertheless, the specific functions and underl...
| Published in: | BMC Gastroenterology |
|---|---|
| Main Authors: | , , , |
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-04-01
|
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12876-025-03820-3 |
